| RS1786516110 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786518484 |
EGFR
|
Health Risk |
Likely pathogenic |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS1786532924 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786558070 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786558148 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786558577 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786631768 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS1786667696 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786669549 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786673966 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786674391 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1786675239 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786713307 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786714587 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786746301 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786750679 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786770612 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786823829 |
ARID1B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1786833331 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1786839596 |
PGM3
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS1786845541 |
PGM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 23, Inborn genetic diseases |
| RS1786848141 |
DNAH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1786857910 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786860270 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1786864520 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS1786877657 |
PKD1L1
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1786879628 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1786880122 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786894242 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1786959370 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1787002281 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS1787039042 |
SEC63
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS1787041288 |
SEC63
|
Health Risk |
Likely pathogenic |
Polycystic liver disease 2, Autosomal dominant polycystic liver disease |
| RS1787058325 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1787059737 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1787098071 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS1787109472 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS1787127981 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1787131313 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1787139771 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS1787146494 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1787147374 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS1787147868 |
GLI3
|
Health Risk |
Pathogenic |
polysyndactyly, polysyndactyly |
| RS1787150198 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1787156507 |
PKD1L1
|
Health Risk |
Likely pathogenic |
PKD1L1-related disorder, PKD1L1-related disorder |
| RS1787180396 |
GLI3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1787181000 |
GLI3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1787182897 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1787185991 |
GLI3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1787228771 |
CDK13
|
Health Risk |
Pathogenic |
— |
| RS1787294032 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Median cleft lip and palate, Dysgenesis of the cerebellar vermis |
| RS1787347907 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome with ocular defect, Joubert syndrome with ocular defect |
| RS1787388036 |
GNAI1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS1787394130 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS1787407031 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Ovarian cancer |
| RS1787407972 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS1787409872 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS1787457978 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1787541407 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1787601205 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS17876032 |
F12
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 3, Factor XII deficiency disease |
| RS1787715929 |
PKD1L1
|
Health Risk |
Likely pathogenic |
PKD1L1-related disorder, PKD1L1-related disorder |
| RS1787740370 |
BLTP1
|
Health Risk |
Pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS1787750092 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS1787768161 |
PKD1L1
|
Health Risk |
Likely pathogenic |
— |
| RS1787819788 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1787830570 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS17878522 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1787859607 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS1787861114 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1787862380 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1787875866 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS17878854 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group G |
| RS17879189 |
PHOX2B
|
Health Risk |
Pathogenic |
Neuroblastoma, susceptibility to |
| RS17879961 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
CHEK2-related cancer predisposition, Hereditary cancer-predisposing syndrome |
| RS17880082 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group G |
| RS1788056577 |
PGM3
|
Health Risk |
Likely pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS1788069498 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1788074933 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1788076877 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1788078377 |
SEMA3E
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1788083949 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1788086604 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia 7 |
| RS17881753 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS17881780 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS1788192479 |
PGM3
|
Health Risk |
Likely pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS1788219551 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS17882252 |
TP53
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS17882922 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS17882942 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS17883172 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS17883283 |
CAPN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Uveal melanoma, Uveal melanoma |
| RS1788331355 |
BMPER
|
Health Risk |
Pathogenic |
— |
| RS17883400 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondroplasia, Inborn genetic diseases |
| RS17883862 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1788391157 |
SNX10
|
Health Risk |
Pathogenic |
— |
| RS17884050 |
FCSK
|
Health Risk |
Conflicting classifications of pathogenicity |
FCSK-related disorder, FCSK-related disorder |
| RS17884120 |
MMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1788434297 |
GNAI1
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS1788434338 |
GNAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder with hypotonia |